Fingerprint
Dive into the research topics of 'No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer
KConFab investigators, Ovarian Cancer Association Consortium, Breast Cancer Association Consortium, Consortium of Modifiers of BRCA1 and BRCA2, Australian Ovarian Cancer Study Group, Australian Ovarian Cancer Study Group, Australian Ovarian Cancer Study Group, GEMO Study Collaborators
Research output: Contribution to journal › Review article › peer-review
10
Scopus
citations